Abstract
Vitamin D and calcium are considered crucial for the treatment of bone diseases. Both vitamin D and calcium contribute to bone homeostasis but also preserve muscle health by reducing the risk of falls and fractures. Low vitamin D concentrations result in secondary hyperparathyroidism and contribute to bone loss, although the development of secondary hyperparathyroidism varies, even in patients with severe vitamin D deficiency. Findings from observational studies have shown controversial results regarding the association between bone mineral density and vitamin D/calcium status, thus sparking a debate regarding optimum concentrations of 25-hydroxyvitamin D and calcium for the best possible skeletal health. Although most of the intervention studies reported a positive effect of supplementation with calcium and vitamin D on bone in patients with osteoporosis, this therapeutic approach has been a matter of debate regarding potential side effects on the cardiovascular (CV) system. Thus, the aim of this review is to consider the current evidence on the physiological role of vitamin D and calcium on bone and muscle health. Moreover, we provide an overview on observational and interventional studies that investigate the effect of vitamin D and calcium supplementation on bone health, also taking into account the possible CV side-effects. We also provide molecular insights on the effect of calcium plus vitamin D on the CV system.
Keywords: Vitamin D, cardiovascular system, calcium, myocardial infarction, stroke, bone health.
Graphical Abstract
[1]
Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd JM. Treatment of established osteoporosis: A systematic review and cost-utility analysis. Health Technol Assess 2002; 6: 1-146.
[3]
Rizzoli R, Stevenson JC, Bauer JM, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Maturitas 2014; 79: 122-32.
[4]
Kuo IY, Ehrlich BE. Signaling in muscle contraction. Cold Spring Harb Perspect Biol 2015; 7006023
[5]
Gehlert S, Bloch W, Suhr F. Ca2+ dependent regulations and signaling in skeletal muscle: From electro-mechanical coupling to adaptation. Int J Mol Sci 2015; 16: 1066-95.
[7]
Rodman JS, Baker T. Changes in the kinetics of muscle contraction in vitamin D-depleted rats. Kidney Int 1978; 13: 189-93.
[8]
Muscogiuri G, Altieri B, Annweiler C, et al. Vitamin D and chronic diseases: The current state of the art. Arch Toxicol 2017; 91: 97-107.
[9]
Roux C, Bischoff-Ferrari HA, Papapoulos SE, de Papp AE, West JA, Bouillon R. New insights into the role of vitamin D and calcium in osteoporosis management: An expert roundtable discussion. Curr Med Res Opin 2008; 24: 1363-70.
[10]
Reid IR, Bristow SM, Bolland MJ. Cardiovascular complications of calcium supplements. J Cell Biochem 2015; 116: 494-501.
[11]
Chalupka S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction, stroke, and overall cardiovascular mortality. Workplace Health Saf 2012; 60: 372.
[12]
Thiele I, Linseisen J, Meisinger C, et al. Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes. Atherosclerosis 2015; 241: 743-51.
[13]
Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-41.
[14]
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-8.
[15]
Ross AC, Taylor CL, Yaktine AL, del Valle HB, Eds. Dietary reference intakes for calcium and vitamin D Institute of Medicine. Washington, DC: The National Academies Press 2011.
[16]
Lips P. Interaction between vitamin D and calcium. Scand J Clin Lab Invest Suppl 2012; 243: 60-4.
[17]
Bolland MJ, Leung W, Tai V, et al. Calcium intake and risk of fracture: Systematic review. BMJ 2015; 351: h4580.
[19]
Lai JK, Lucas RM, Clements MS, Roddam AW, Banks E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: A systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health 2010; 10: 331.
[20]
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures inthe elderly women. N Engl J Med 1992; 327: 1637-42.
[21]
Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyreoidism and hip fracture risk: The Decalos II study. Osteoporos Int 2002; 13: 257-64.
[22]
Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014; 4CD000227
[24]
Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 2014; 25: 2359-81.
[25]
Bhattoa HP, Konstantynowicz J, Laszcz N, Wojcik M, Pludowski P, Vitamin D. Musculoskeletal health. Rev Endocr Metab Disord 2017; 18: 363-71.
[26]
Pludowski P, Holick MF, Grant WB, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 2018; 175: 125-35.
[27]
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
[28]
Pludowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64: 319-27.
[29]
Haq A, Wimalawansa SJ, Pludowski P, Al Anouti F. Clinical practice guidelines for vitamin D in the United Arab Emirates. J Steroid Biochem Mol Biol 2018; 175: 4-11.
[30]
Michaëlsson K, Melhus H, Warensjö Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ 2013; 346: 228.
[31]
Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998; 98: 1198-204.
[32]
Anagnostis P, Athyros VG, Adamidou F, Florentin M, Karagiannis A. Vitamin D and cardiovascular disease: A novel agent for reducing cardiovascular risk? Curr Vasc Pharmacol 2010; 8: 720-30.
[33]
Anagnostis P, Paschou SA, Goulis DG. Vitamin D supplementation and cardiovascular disease risk. JAMA Cardiol 2017; 2: 1281-2.
[34]
Van der Vijver LP, Van der Waal MA, Weterings KG, Dekker JM, Schouten EG, Kok FJ. Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. Int J Epidemiol 1992; 21: 36-9.
[35]
Savanelli MC, Scarano E, Muscogiuri G, et al. Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: Is there a role for vitamin D? Endocrine 2016; 52: 111-9.
[36]
Samelson EJ, Booth SL, Fox CS, et al. Calcium intake is not associated with increased coronary artery calcification: The Framingham study. Am J Clin Nutr 2012; 96: 1274-80.
[37]
Ahmad MI, Chevli PA, Li Y, Soliman EZ. Vitamin D deficiency and electrocardiographic subclinical myocardial injury: Results from national health and nutrition examination survey-III. Clin Cardiol 2018; 41: 1468-73.
[38]
Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials. Lipids Health Dis 2012; 11: 42.
[39]
Savastano S, Barrea L, Savanelli MC, et al. Low vitamin D status and obesity: Role of nutritionist. Rev Endocr Metab Disord 2017; 18: 215-25.
[40]
Barrea L, Savastano S, Di Somma C, et al. Low serum vitamin D-status, air pollution and obesity: A dangerous liaison. Rev Endocr Metab Disord 2017; 18: 207-14.
[41]
Muscogiuri G, Barrea L, Scannapieco M, et al. The lullaby of the sun: The role of vitamin D in sleep disturbance. Sleep Med 2018; 54: 262-5.
[42]
Di Somma C, Scarano E, Barrea L, et al. Vitamin D and neurological diseases: An endocrine view. Int J Mol Sci 2017; 18 pii:E2482
[43]
Barrea L, Savanelli MC, Di Somma C, et al. Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. Rev Endocr Metab Disord 2017; 18: 195-205.
[44]
Dan Q, Xiao-lu N, Shouling W, Jun C. Vitamin D and hypertension: Prospective study and meta-analysis. PLoS One 2017; 12e0174298
[45]
Scragg R, Stewart AW, Waayer D, et al. Effect of monthly high-dose vitamin d supplementation on cardiovascular disease in the vitamin d assessment study: A randomized clinical trial. JAMA Cardiol 2017; 2: 608-16.
[46]
Manson JE, Cook NR, Lee IM, et al. Vitamin d supplements and prevention of cancer and cardiovascular disease. N Engl J Med 2019; 380: 33-44.
[47]
Knox EG. Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet 1973; 1: 1465-7.
[48]
Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999; 149: 151-61.
[49]
Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 1999; 30: 1772-9.
[50]
Shah S, Chiang C, Sikaris K, et al. Serum 25-hydroxyvitamin D insufficiency in search of a bone disease. J Clin Endocrinol Metab 2017; 102: 2321-8.
[51]
Reid IR, Ames R, Mason B, et al. Effects of calcium supplementation on lipids, blood pressure and body composition in healthy older men: A randomized controlled trial. Am J Clin Nutr 2010; 91: 131-9.
[52]
Trautvetter U, Ditscheid B, Jahreis G, Glei M. Habitual intakes, food sources and excretions of phosphorus and calcium in three german study collectives. Nutrients 2018; 10:pii: E171..
[53]
Chang AR, Lazo M, Appel LJ, Gutiérrez OM, Grams ME. High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III. Am J Clin Nutr 2014; 99: 320-7.
[54]
Van Mierlo LA, Arends LR, Streppel MT, et al. Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J Hum Hypertens 2006; 20: 571-80.
[55]
Gallo L, Faniello MC, Canino G, et al. Serum calcium increase correlates with worsening of lipid profile: An observational study on a large cohort from south Italy. Medicine 2016; 95e2774
[56]
Radwan SF, Ghada II, Gamal AE, Osama AA, Mohamad TM. High dietary calcium and weight regulation in mature and premature rats. Med J Cairo Univ 2012; 80: 715-23.
[57]
De Abajo FJ, Rodríguez-Martín S, Rodríguez-Miguel A, Gil MJ. Risk of ischemic stroke associated with calcium supplements with or without vitamin D: A nested case-control study. J Am Heart Assoc 2017; 6 pii: e005795
[58]
Hagen G, Wisloff T, Kristiansen IS. The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects. Osteoporos Int 2016; 27: 2089-98.
[59]
Kern J, Kern S, Blennow K, et al. Calcium supplementation and risk of dementia in women with cerebrovascular disease. Neurology 2016; 87: 1674-80.
[60]
Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691.
[61]
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: Reanalysis of the women’s health initiative limited access dataset and meta-analysis. BMJ 2011; 342: 2040.
[62]
Brazier M, Grados F, Kamel S, et al. Clinical and laboratory safety of one year’s use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: Results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2005; 27: 1885-93.
[63]
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National health and nutrition examination survey. JAMA 2000; 283: 2404-10.
[64]
Julien M, Magne D, Masson M, et al. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 2007; 148: 530-7.
[65]
David V, Dai B, Martin A, Huang J, Han X, Quarles DL. Calcium regulates FGF-23 expression in bone. Endocrinology 2013; 154: 4469-82.
[66]
Alam M, Kirton JP, Wilkinson FL, et al. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells. Cardiovasc Res 2009; 81: 260-8.
[67]
House M, Kohlmeier L, Chattopadhyay N, et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res 1997; 12: 1959-70.
[68]
Lewis JR, Radavelli-Bagatini S, Rejnmark L, et al. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: A collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 2015; 30: 165-75.
[69]
Weaver CM. Calcium supplementation: Is protecting against osteoporosis counter to protecting against cardiovascular disease? Curr Osteoporos Rep 2014; 12: 211-8.
[70]
Harvey NC, Biver E, Kaufman JM, et al. The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) and the international foundation for osteoporosis (IOF). Osteoporos Int 2017; 28: 447-62.
[71]
Chin K, Appel LJ, Michos ED. Vitamin D, calcium, and cardiovascular disease: A “D” vantageous or “D” etrimental? An Era of Uncertainty. Curr Atheroscler Rep 2017; 19: 5.
[72]
Guessous I, Bochud M, Bonny O, Burnier M. Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res 2011; 34: 404-17.
[73]
Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007; 115: 846-54.
[74]
Avenell A, MacLennan GS, Jenkinson DJ, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD trial). J Clin Endocrinol Metab 2012; 97: 614-22.
[75]
NC, D'Angelo S, Paccou J, et al.Calcium and vitamin D supplementation are not associated with risk of incident ischemic cardiac events or death: Findings from the UK biobank cohort. J Bone Miner Res 2018; 33: 803-11.
[76]
Annweiler C, Legrand E, Souberbielle JC. Vitamin D in adults: Update on testing and supplementation. Geriatr Psychol Neuropsychiatr Vieil 2018; 16: 7-22.
[77]
Simpson RU, Thomas GA, Arnold AJ. Identification of 1, 25-dihydroxy vitamin D3 receptors and activities in muscle. J Biol Chem 1985; 260: 8882-91.
[78]
Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33: 19-24.
[79]
Fraga C, Blanco M, Vigo E, Segura C, García-Caballero T, Pérez-Fernández R. Ontogenesis of the vitamin D receptor in rat heart. Histochem Cell Biol 2002; 117: 547-50.
[80]
Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 2008; 52: 1106-12.
[81]
David GG, Songcang C, Denis JG. Vitamin D and the heart. Am J Physiol Regul Integr Comp Physiol 2013; 305: 969-77.
[82]
Wang GF, Nikovits W, Schleinitz M, Stockdale FE. Atrial chamber-specific expression of the slow myosin heavy chain 3 gene in the embryonic heart. J Biol Chem 1996; 271: 19836-45.
[83]
Tishkoff DX, Nibbelink KA, Holmberg KH, Dandu L, Simpson RU. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2007; 149: 558-64.
[84]
Weber KT, Weglicki WB, Simpson RU. Macro-and micronutrient dyshomeostasis in the adverse structural remodelling of myocardium. Cardiovasc Res 2009; 81: 500-8.
[85]
Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM 2002; 95: 787-96.
[86]
Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568-75.
[87]
Oh J, Weng S, Felton SK, et al. 25 (OH) 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-98.
[88]
Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. J Clin Invest 1987; 79: 1706-12.
[89]
Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol 1990; 258: 134-42.
[90]
Oconnell TD, Simpson RU. 25-Dihydroxyvitamin D3 regulation of myocardial growth and C-MYC levels in the rat heart. Biochem Biophys Res Commun 1995; 213: 59-65.
[91]
Gezmish O, Tare M, Parkington HC, et al. Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reprod Sci 2010; 17: 168-76.
[92]
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38.
[93]
Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 288: 125-32.
[94]
Yuan W, Pan W, Kong J, et al. 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 2007; 282: 29821-30.
[95]
Simpson RU, Hershey SH, Nibbelink KA. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007; 103: 521-4.
[96]
Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 2007; 103: 416-9.
[97]
Heaney RP, Kopecky S, Maki KC, Hathcock J, Mackay D, Wallace TC. A review of calcium supplements and cardiovascular disease risk. Adv Nutr 2012; 3: 763-71.
[98]
Yacowitz H, Fleischman A, Bierenbaum M, Kritchevsky D. Calcium and lipid metabolism: effects of increased dietary calcium on atherosclerosis in rabbits. Trans N Y Acad Sci 1971; 33: 344-50.
[99]
Fleischman A, Yacowitz H, Hayton T, Bierenbaum M. Effects of dietary calcium upon lipid metabolism in mature male rats fed beef tallow. J Nutr 1966; 88: 255-60.
[100]
Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987; 262: 14385-8.
Call for Papers in Thematic Issues
31 January, 2025
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Related Books
Anthocyanins: Pharmacology and Nutraceutical Importance
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Advanced Pharmacy
Plant-derived Hepatoprotective Drugs
The Role of Chromenes in Drug Discovery and Development
Article Metrics
70
6